ENTITY
Roche Holding

Roche Holding (RO SE)

65
Analysis
Health Care • United States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
•25 Feb 2026 19:53

Global Stock Positioning: Tech Dominance, China Rotation, and Record TSMC Ownership

Technology continues to anchor global active portfolios, with TSMC at record ownership. Rotation persists across regions as managers selectively...

Logo
492 Views
Share
•24 Dec 2025 09:19•Broker

[2026 Outlook] Pharma/BiotechIdentifying Leaders Within an Outperforming Sector

In 1H25, US policy uncertainty—i.e., potential drug tariffs, the most-favored-nation (MFN) pricing proposal, and Inflation Reduction Act (IRA) drug...

Logo
358 Views
Share
bullish•Bioventix
•30 Sep 2026 08:34

Bioventix Revisited: The Bond Proxy That Forgot Its Maturity Date

Bioventix's margins and dividends held, yet the shares fell 61%. Our 2021 bond-proxy thesis ignored that royalties mature. Why the setup has...

Logo
89 Views
Share
•16 Nov 2025 08:30

APAC Healthcare Weekly (November 16) – Leads Bio, Henlius Bio, Otsuka, ABL Bio, Boryung, Eubiologics

Henlius got FDA approval for Perjeta biosimilar. Otsuka reports positive Phase 3 trial result for sibepernlimab. ABL Bio signed deal with Lilly....

Logo
601 Views
Share
•19 Oct 2025 08:30

APAC Healthcare Weekly (October 19) – Hansoh, Leads Biolabs, Chugai, SanBio, Celltrion, Samsung Bio

Hansoh and Leads Biolabs bag global outlicensing deals. Chugai’s partner Lilly announced positive P3 result for orforglipron. Celltrion launched...

Logo
1k Views
Share
x